A
Aprimus Diagnostics develops quantitative blood testing solutions utilizing new chemistry technology for improved accuracy, convenience, and affordability. The company focuses on diagnostic and monitoring tools for personalized care, including assays for D-Dimer, tumor markers, and mental health biomarkers. These products aim to facilitate early treatment starts and optimize patient outcomes through convenient monitoring of medication regimens.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Aprimus Diagnostics develops quantitative blood testing solutions utilizing new chemistry technology for improved accuracy, convenience, and affordability. The company focuses on diagnostic and monitoring tools for personalized care, including assays for D-Dimer, tumor markers, and mental health biomarkers. These products aim to facilitate early treatment starts and optimize patient outcomes through convenient monitoring of medication regimens.